Sign in

CIK 0001856725

  • Emerging growth company

Rani Therapeutics Holdings, Inc.

Sign in to watch
Ticker
RANI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
863114789
Phone
+1 408-457-3700
Business address
47709 FREMONT BLVD, FREMONT, CA, 94538
  1. 4 Conversion Director acquired 7,694 shares (conversion)
  2. 4 Conversion Director acquired 7,694 shares (conversion)
  3. 4 Open-market sale Director sold 80,252 shares at an average $10.64 ($853,672)
  4. 4 Open-market sale Director sold 80,252 shares at an average $10.64 ($853,672)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Chief Executive Officer acquired 86,600 shares (grant or award)
  14. 4 Grant or award Chief Financial Officer acquired 32,900 shares (grant or award)
  15. 4 Grant or award Chief Scientific Officer acquired 41,200 shares (grant or award)
  16. 4 Grant or award General Counsel acquired 24,500 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Conversion Director acquired 2,309,490 shares (conversion)
  19. 4 Conversion Director acquired 2,309,490 shares (conversion)
  20. 4 Other disposition Chief Executive Officer disposed of 827,467 shares (other)

Page 8 of 10 · 194 filings